Showing 221-230 of 718 results for "".
Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-21/23421/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-11/23225/Do I Really Need an Investment Advisor?
https://practicaldermatology.com/topics/practice-management/do-i-really-need-an-investment-advisor/20866/Nine reasons physician-investors underperform without professional investment advice.The Dermatology Market: A Tidal Wave of Private Equity Investment
https://practicaldermatology.com/topics/practice-management/the-dermatology-market-a-tidal-wave-of-private-equity-investment/20416/A beginner's guide to the complex world of mergers and acquisitions.Advances in Topical Acne Therapy
https://practicaldermatology.com/topics/practice-management/advancesin-topical-acne-therapy/21020/Even severe acne patients can be safely—and effectively—treated with topicals today.What's New in Topical Acne Therapy
https://practicaldermatology.com/topics/practice-management/whats-new-in-topical-acne-therapy/21105/From new approvals to a growing pipeline, the outlook is bright for the continued refinement of topical acne therapy.Do I Really Need an Investment Advisor?
https://practicaldermatology.com/topics/practice-management/do-i-really-need-an-investment-advisor/21276/The nine reasons physician-investors underperform without professional management.Update on Atopic Dermatitis 2018
https://practicaldermatology.com/topics/general-topics/update-on-atopic-dermatitis-2018/20354/A look at the pathophysiology of AD, including structural and immunologic contributors, as well as new therapeutic developments with an eye toward breakthroughs on the horizon.